Table 5. Multivariate analysis of the associated factors presence of hyperdynamic LV, abnormal LV EF, and mortality.

	Odds ratio	95% CI	p
Presence of hyperdynamic LV
Female gender	3.316	1.251–8.789	0.016
Hospital days	0.998	0.965–1.031	0.883
LAVI	0.974	0.928–1.023	0.295
LVMI	0.998	0.973–1.023	0.855
LVEDD	0.414	0.312–0.550	<0.001
LVESD’	0.221	0.143–0.342	<0.001
S’	1.140	0.946–1.373	0.168
Presence of reduced LV EF
Female gender	1.252	0.654–2.397	0.498
Mortality	1.835	0.895–2.397	0.098
ICU stays	0.976	0.945–1.009	0.150
Hospital days	1.010	0.991–2.397	1.031
LAVI	1.014	0.992–1.037	0.211
Presence of abnormal LV EF
Female gender	1.734	1.059–2.841	0.029
Mortality	1.460	0.829–2.570	0.190
HR	1.011	0.999–1.022	0.064
ICU stays	0.978	0.950–1.006	0.117
Hospital days	1.000	0.983–1.016	0.963
LAVI	0.974	0.952–0.995	0.018
Mortality
HR	1.017	1.005–1.029	0.004
Pneumonia	3.184	1.817–5.580	<0.001
Malignancy	2.949	1.534–5.669	0.001
SAPS3	1.060	1.015–1.106	0.008
Final CRP	1.019	1.010–1.028	<0.001
Final TnI	1.657	1.045–2.630	0.032